Management of patients with refractory Migraine and PFO: Is mist I relevant?

Catheterization and Cardiovascular Interventions

Volumn 72, Issue 1, 2008, Pages 60-64

  Tobis, Jonathan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Embolization; Intracardiac echo; Patent foramen ovale atrial septal defect

Indexed keywords

CLINICAL RESEARCH; DEVICE; MIGRAINE; MIGRAINE INTERVENTION STARFLEX TECHNOLOGY; PATENT FORAMEN OVALE; PATHOLOGY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; REVIEW; STROKE; TECHNOLOGY;

CONFLICT OF INTEREST; DISCLOSURE; FORAMEN OVALE, PATENT; HEART CATHETERIZATION; HUMANS; MIGRAINE WITH AURA; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 47549104799     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21504     Document Type: Review

References (16)

1. Homma S, et al. Effect of medical treatment in stroke patients with patent foramen ovale: Patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002;105:2625-2631.
2. Kessel-Schaefer A, et al. Migrating thrombus trapped in a patent foramen ovale. Circulation 2001;103:1928.
3. Lechat P, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-1152.
4. Di Tullio M, et al. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992;117:461-465.
5. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000; 55:1172-1179.
6. Mas JL, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-1746.
7. Anzola GP, Magoni M, et al. Potential source of cerebral embolism in migraine with aura: A transcranial Doppler study. Neurology 1999;52:1622-1625.
8. Azarbal B, Tobis J, et al. Association of interatrial shunts and migraine headaches. J AM Coll Cardiol 2005;45:489-492.
9. Del Sette M, Angeli S, et al. Migraine with aura and right-to-left shunt on transcranial Doppler: A case control study. Cerebrovasc Dis 1998;8:327-330.
10. Domitrz I, Mieszkowski J, Kaminska A. Relationship between migraine and patent foramen ovale: A study of 121 patients with migraine. Headache 2007;47:1311-1318.
11. Reisman M, Christofferson RD, Jesurum J, et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005;45:493-495.
12. Schwerzmann M, Wiher S, Nedeltchev K, et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004;62:1399-1401.
13. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000;356:1648-1651.
14. Slavin L, Tobis JM, Rangarajan K, Dao C, Krivokapich J, Lie-beskind DS. Five-year experience with percutaneous closure of patent foramen ovale. Am J Cardiol 2007;99:1316-1320.
15. Silberstein SD, Neto W, Schmitt J, Jacobs D, MIGR-001 Study Group. Topiramate in migraine prevention: Results of a large controlled trial. Arch Neurol 2004;61:490-495.
16. Dowson ATJ. MIST I and MIST III Trials. TCT Presentations. Washington DC; 2007.